First Trust Health Care AlphaDEX FXH
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Net expense ratio
- 0.61%
- Net assets
- $1.0B
- Holdings
- 75
- 12-month distribution yield
- 0.55%
- Asset class
- Equity
First Trust Health Care AlphaDEX (FXH) is an exchange-traded fund listed on NYSE Arca in the United States, issued by First Trust. Its category is Equity · US (equity). Its last price was US$135.05 on 20 Oct 2026. Its net expense ratio is 0.61% a year, from its prospectus dated 1 Dec 2025. It reported net assets of US$1.05 billion as of 31 Jul 2026. Its latest holdings report lists 75 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$0.74 a unit, a 12-month distribution yield of 0.55%, paid quarterly.
Fees
- Total annual operating expenses (gross)
- 0.61%
- Net, after fee waivers or reimbursements
- 0.61%
- Management fee
- 0.50%
- Prospectus date
- 1 Dec 2025
- Filed with the SEC
- 28 Nov 2025
Size and reporting
- Net assets
- $1,047,836,140
- Total assets
- $1,048,651,550
- Holdings as of
- 31 Jul 2026
- Report made public
- 22 Sep 2026 (53 days after the month end)
Top holdings
Largest 25 of 75 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | REGENERON PHARMACEUTICALS INC REGENERON PHARMACEUTICALS INC COM | US75886F1075 | 2.77% | $29.0M | Equity (common) | United States | USD |
| 2 | UNIVERSAL HEALTH SERVICES INC UNIVERSAL HEALTH SERVICES INC CL B | US9139031002 | 2.57% | $26.9M | Equity (common) | United States | USD |
| 3 | SOLVENTUM CORP SOLVENTUM CORP COM SHS | US83444M1018 | 2.51% | $26.3M | Equity (common) | United States | USD |
| 4 | BOSTON SCIENTIFIC CORP BOSTON SCIENTIFIC CORP COM | US1011371077 | 2.48% | $26.0M | Equity (common) | United States | USD |
| 5 | ZIMMER BIOMET HOLDINGS INC ZIMMER BIOMET HOLDINGS INC COM | US98956P1021 | 2.47% | $25.9M | Equity (common) | United States | USD |
| 6 | GUARDANT HEALTH INC GUARDANT HEALTH INC COM | US40131M1099 | 2.45% | $25.6M | Equity (common) | United States | USD |
| 7 | DAVITA INC DAVITA INC COM | US23918K1088 | 2.44% | $25.6M | Equity (common) | United States | USD |
| 8 | PFIZER INC PFIZER INC COM | US7170811035 | 2.35% | $24.6M | Equity (common) | United States | USD |
| 9 | TENET HEALTHCARE CORP TENET HEALTHCARE CORP COM NEW | US88033G4073 | 2.30% | $24.1M | Equity (common) | United States | USD |
| 10 | CIGNA GROUP (THE) CIGNA GROUP (THE) COM | US1255231003 | 2.29% | $24.0M | Equity (common) | United States | USD |
| 11 | GLOBUS MEDICAL INC GLOBUS MEDICAL INC CL A | US3795772082 | 2.26% | $23.7M | Equity (common) | United States | USD |
| 12 | MEDLINE INC MEDLINE INC COM CL A | US58507V1070 | 2.26% | $23.6M | Equity (common) | United States | USD |
| 13 | NATERA INC NATERA INC COM | US6323071042 | 2.23% | $23.4M | Equity (common) | United States | USD |
| 14 | CORCEPT THERAPEUTICS INC CORCEPT THERAPEUTICS INC COM | US2183521028 | 2.23% | $23.3M | Equity (common) | United States | USD |
| 15 | CENTENE CORP CENTENE CORP COM | US15135B1017 | 2.20% | $23.0M | Equity (common) | United States | USD |
| 16 | AXSOME THERAPEUTICS INC AXSOME THERAPEUTICS INC COM | US05464T1043 | 2.02% | $21.1M | Equity (common) | United States | USD |
| 17 | ENCOMPASS HEALTH CORP ENCOMPASS HEALTH CORP COM | US29261A1007 | 1.86% | $19.5M | Equity (common) | United States | USD |
| 18 | MEDTRONIC PLC MEDTRONIC PLC SHS | IE00BTN1Y115 | 1.85% | $19.3M | Equity (common) | Ireland | USD |
| 19 | RESMED INC RESMED INC COM | US7611521078 | 1.83% | $19.2M | Equity (common) | United States | USD |
| 20 | ZOETIS INC ZOETIS INC CL A | US98978V1035 | 1.82% | $19.1M | Equity (common) | United States | USD |
| 21 | QIAGEN NV QIAGEN NV ORD SHARES | NL0015002SN0 | 1.79% | $18.8M | Equity (common) | Netherlands | USD |
| 22 | HALOZYME THERAPEUTICS INC HALOZYME THERAPEUTICS INC COM | US40637H1095 | 1.78% | $18.7M | Equity (common) | United States | USD |
| 23 | INCYTE CORP INCYTE CORP COM | US45337C1027 | 1.78% | $18.7M | Equity (common) | United States | USD |
| 24 | ARROWHEAD PHARMACEUTICALS INC ARROWHEAD PHARMACEUTICALS INC COM | US04280A1007 | 1.76% | $18.4M | Equity (common) | United States | USD |
| 25 | NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC COM | US64125C1099 | 1.67% | $17.5M | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.82% | |
| Short-term investment vehicles (cash funds) | 0.17% | |
| Repurchase agreements | <0.01% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 93.34% | |
| Ireland | 3.32% | |
| Netherlands | 1.79% | |
| Denmark | 1.55% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 100.00% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 84.75% | |
| Industrials | 3.18% | |
| Technology | 2.98% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $0.7360
- 12-month yield
- 0.55%
- Frequency
- Quarterly
- Latest ex-date
- 24 Sep 2026
12-month yield = distributions per unit with an ex-date in the last 12 months ($0.7360) ÷ latest price ($135.05) × 100 = 0.55%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (17 payments)
| Ex-date | Amount per unit |
|---|---|
| 24 Sep 2026 | $0.2920 |
| 25 Jun 2026 | $0.1180 |
| 26 Mar 2026 | $0.1860 |
| 12 Dec 2025 | $0.1400 |
| 25 Sep 2025 | $0.5820 |
| 26 Jun 2025 | $0.0620 |
| 27 Mar 2025 | $0.0670 |
| 13 Dec 2024 | $0.0900 |
| 26 Sep 2024 | $0.1260 |
| 27 Jun 2024 | $0.1090 |
| 21 Mar 2024 | $0.1060 |
| 22 Dec 2023 | $0.1300 |
| 22 Sep 2023 | $0.0330 |
| 27 Jun 2023 | $0.0380 |
| 24 Mar 2023 | $0.0440 |
| 23 Dec 2022 | $0.1210 |
| 23 Sep 2022 | $0.1010 |
Filings and sources
- Form N-PORT report for July 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000017700) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- FXH and VTI Vanguard Morningstar Total Stock Market ETF
- FXH and VOO Vanguard S&P 500 ETF
- FXH and IVV iShares Core S&P 500 ETF
- FXH and QQQ Invesco QQQ Trust, Series 1